Investor alert: law offices of howard g. smith announces investigation of amryt pharma plc (amyt) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of amryt pharma plc (“amryt” or the “company”) (nasdaq: amyt) investors concerning the company's possible violations of federal securities laws. on february 28, 2022, amryt disclosed receipt of a complete response letter (“crl”) from the u.s. food and drug administration (“fda”) stating that the company's new drug application for its dystrophic and junctional epidermolysis bullosa (“eb”) treatmen
AMYT Ratings Summary
AMYT Quant Ranking